SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Chase Garrett L.

(Last) (First) (Middle)
C/O DELTA AIR LINES, INC., DEPT. 981
P.O. BOX 20574

(Street)
ATLANTA GA 30320

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/16/2020
3. Issuer Name and Ticker or Trading Symbol
DELTA AIR LINES, INC. [ DAL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Co-CFO, SVP, BusDev & FinPlan
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 14,313(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (2) 02/01/2027 Common Stock 9,390 $49.33 D
Employee Stock Option (right to buy) (3) 02/07/2028 Common Stock 12,140 $51.23 D
Employee Stock Option (right to buy) (4) 02/05/2029 Common Stock 11,110 $50.52 D
Explanation of Responses:
1. Represents shares of restricted common stock. Of these restricted shares, (i) 2,733 were granted to the Reporting Person on February 8, 2018 and will vest on February 1, 2021, (ii) 4,440 were granted to the Reporting Person on February 6, 2019 and will vest in two equal installments on February 1, 2021 and 2022 and (iii) 7,140 were granted on February 5, 2020 and will vest in three equal installments on February 1, 2021, 2022 and 2023. The grants of restricted stock were approved by the Personnel & Compensation Committee ("P&C Committee") of Delta's Board of Directors and are exempt from Section 16(b) of the Securities Exchange Act of 1934 ("Exchange Act") under Rule 16b-3(d).
2. On February 9, 2017, the P&C Committee granted to the Reporting Person an option to purchase 9,390 shares of common stock. The option vested subject to Delta's satisfaction of certain performance criteria, which were certified by the P&C Committee on February 8, 2018. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d).
3. On February 8, 2018, the P&C Committee granted to the Reporting Person an option to purchase 12,140 shares of common stock. The option vests subject to Delta's satisfaction of certain performance criteria. Because the performance criteria were met, as certified by the P&C Committee on February 6, 2019, the option as to 8,094 shares has vested; the option for the remaining 4,046 shares will vest on February 1, 2021. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d).
4. On February 6, 2019, the P&C Committee granted to the Reporting Person an option to purchase 11,110 shares of common stock. The option vests subject to Delta's satisfaction of certain performance criteria. Because the performance criteria were met, as certified by the P&C Committee on February 5, 2020, the option as to 3,704 shares has vested; the option for the remaining 7,406 shares will vest in two equal installments on February 1, 2021 and 2022. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d).
Remarks:
Co-CFO, SVP, Business Development & Financial Planning
/s/ Stephanie W. Bignon as attorney-in-fact for Garrett L. Chase 11/24/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.